(2Z)-3-[2-(4-Chlorophenyl)-7-methylimidazo[1,2-a]pyridin-3-yl]-2-(pyridin-2-yl)prop-2-enenitrile

Catalog No. :
ACLAOL576
CAS No. :
477847-68-0
Molecular Formula :
C22H15ClN4
Molecular Weight :
370.84

IUPAC Name:(Z)-3-(2-(4-chlorophenyl)-7-methylimidazo[1,2-a]pyridin-3-yl)-2-(pyridin-2-yl)acrylonitrile

(2Z)-3-[2-(4-Chlorophenyl)-7-methylimidazo[1,2-a]pyridin-3-yl]-2-(pyridin-2-yl)prop-2-enenitrile structure diagram
Pack SizePurityList PriceYour PriceGlobal StockUS StockQuantity
1g90%$280.00Login to see priceInquiryInquiry

Products of AiFChem are all designed for scientific research only. Under no circumstances do we provide products or services for animal or personal utilization.

Product Information

Product Name(2Z)-3-[2-(4-Chlorophenyl)-7-methylimidazo[1,2-a]pyridin-3-yl]-2-(pyridin-2-yl)prop-2-enenitrile
IUPAC Name(Z)-3-(2-(4-chlorophenyl)-7-methylimidazo[1,2-a]pyridin-3-yl)-2-(pyridin-2-yl)acrylonitrile
Molecular FormulaC22H15ClN4
Molecular Weight370.84
SMILESN#C/C(C1=NC=CC=C1)=C\C2=C(C3=CC=C(Cl)C=C3)N=C4C=C(C)C=CN42
InChI KeyDPXIKNRUQJIOML-GHRIWEEISA-N
Synonym(Z)-3-[2-(4-CHLOROPHENYL)-7-METHYLIMIDAZO[1,2-A]PYRIDIN-3-YL]-2-(2-PYRIDINYL)-2-PROPENENITRILE;(2Z)-3-[2-(4-chlorophenyl)-7-methylimidazo[1,2-a]pyridin-3-yl]-2-(pyridin-2-yl)prop-2-enenitrile;2-Pyridineacetonitrile, α-[[2-(4-chlorophenyl)-7-methylimidazo[1,2-a]pyridin-3-yl]methylene]-
CAS No.477847-68-0

Synthetic Route by SureRoute

1. ACLAOL576 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. ACWOQI416 route compound structure diagram
    ACWOQI4162739-97-1 In Stock
  4. Then
  5. ACLAOL576 route product structure diagram
    ACLAOL576477847-68-0
Inquiry

2. ACLAOL576 Molecular Building Block Synthetic Route

Source: SureRouteAuthor: aifchem

  1. reactant_1 route compound structure diagram
    --
  2. Plus
  3. reactant_2 route compound structure diagram
    --
  4. Then
  5. ACLAOL576 route product structure diagram
    ACLAOL576477847-68-0
Inquiry

Comments (0)